A BRD2 and BRD4 inhibitor
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

BRD4 Inhibitor 20

Item No. 46738

Technical Information
Formal Name
N-[2,3-dihydro-3-(1-methylethylidene)-2-oxo-1H-indol-5-yl]-2-methoxy-benzenesulfonamide
CAS Number
2490311-14-1
Synonyms
  • Bromodomain containing protein 4-IN-20
  • Bromodomain containing protein 4 Inhibitor 20
  • BRD4-IN-20
  • XY-1
Molecular Formula
C18H18N2O4S
Formula Weight
Purity
≥98%
A solid
DMSO: Soluble: ≥10 mg/ml
SMILES
O=C1NC2=CC=C(NS(=O)(C3=C(C=CC=C3)OC)=O)C=C2/C1=C(C)\C
InChi Code
InChI=1S/C18H18N2O4S/c1-11(2)17-13-10-12(8-9-14(13)19-18(17)21)20-25(22,23)16-7-5-4-6-15(16)24-3/h4-10,20H,1-3H3,(H,19,21)
InChi Key
CDERLIUJSXSXFH-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    BRD4 inhibitor 20 is an inhibitor of bromodomain-containing protein 2 (BRD2) and BRD4 (IC50s = 24, 18, 19, and 28 nM for BRD2 BD1, BRD2 BD2, BRD4 BD1, and BRD4 BD2, respectively).1 It selectively inhibits the proliferation of HL-60 leukemia and HT-29 colon cancer cells over WI38 fibroblasts (IC50s = 1.35, 4.75, and 44.07 µM, respectively) and induces cell cycle arrest at the G1 phase in HT-29 cells. BRD4 inhibitor 20 decreases the levels of protein arginine methyltransferase 1 (PRMT1), PRMT4, PRMT5, PRMT7, and Myc, reduces histone symmetric and asymmetric dimethylarginine levels, and induces apoptosis in MV4-11 and HL-60 leukemia cells.2 It decreases tumor volume in an MV4-11 mouse xenograft model at 30 mg/kg.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Xu, Y., Zhang, X.-J., Li, W.-B., et al. Design, synthesis and biological evaluation of indole-2-one derivatives as potent BRD4 inhibitors. Eur. J. Med. Chem. 208, 112780 (2020).

    2. Dong, S., Yang, R., Wang, Y., et al. A novel 3-alkenylindol-2-one derivative selectively inhibits the growth of acute myeloid leukemia via modulation of the MYC-PRMT pathway. Biochem. Pharmacol. 240, 117111 (2025).